Skip to main content
. 2021 Nov 11;12:767370. doi: 10.3389/fimmu.2021.767370

Figure 6.

Figure 6

Total HIV-1 specific T cell responses measured by IFN-γ ELISPOT: (A) Individual responses and mean ± SEM of SFC/106 PBMC for the different arms of the study at w0 (baseline); (B) Changes of HIV-1-specific T cell responses at w16 for the different arms of the study [Δ SFC/106 PBMC (w16-w0)]. No significant differences were observed between vaccine and placebo groups (p=0.09). No effect on HIV-1-specific T cell responses was observed with the administration of IFN.